The world’s first device for endotracheal intubation that protects clinicians while facilitating the procedure.
Effective barrier for aerosols and droplets, reduces infection risk.
Disruptive concept, smart design, revolutionary technology.
Endotracheal Intubation: An Aerosol Generating Procedure
ETI is a complex and high-risk procedure only performed by highly trained clinicians. More than 50 million intubations are performed worldwide per year. It is the third most common procedure in US hospitals. The global airway management market value is 1.6 billion € per year.
ETI permits mechanical ventilation in patients with severe respiratory failure, in the context of COVID-19 or other causes. It is also required in most surgeries.
It is an aerosol generating procedure (AGP) with high risk of infection for the operators. At present, clinicians represent 5.46 % of total COVID-19 cases in Spain, with a total of more than 79,000 cases.
The current COVID-19 pandemic has compelled the medical community worldwide to search for a device that could make ETI safer, both for patients and for clinicians. In this context, the Airway ShieldTM is a groundbreaking solution: a unique, disposable device that makes intubation safer for both patient and clinical staff, is easy to operate with minimal training, and is highly cost-effective.
The Airway ShieldTM
An innovative low-cost and safe solution for minimizing risks of ETI procedure.
Seal to allow laryngoscope blade and endotracheal tube to pass, while minimizing aerosols and droplets leakage
The ‘Shield’ covers the patient’s mouth and protects the operator from infection
Seal to allow aspiration of secretions and/or aerosols
The ‘Airway’ facilitates intubation by guiding the endotracheal tube towards the larynx
The COVID-19 pandemic has raised an urgent need for adequate protective measures during high-risk aerosol-generating procedures such as endotracheal intubation (ETI).
Current clinical guidelines for airway management encourage clinicians to focus on using appropriate contact and airborne precautions.
The Airway ShieldTM is a cost-effective and revolutionary barrier device that protects medical staff during intubation procedures.
How it works
The simple yet innovative operating mechanism behind the Airway ShieldTM consists in supporting the tongue while creating a channel for the endotracheal tube (ETT), so it can easily follow the direction set by the laryngoscope blade towards the larynx.
1
Placing the Airway ShieldTM
Carefully following the palate, the device is introduced into the mouth until the shield is covering the mouth of the patient. The shield protects the operators from droplets and aerosols.
2
Intubation
Like in a standard intubation, the video-laryngoscope is introduced first to obtain the view of the larynx, and then the ETT is introduced. The channel of the device facilitates the introduction of the ETT following the blade of the laryngoscope towards the larynx.
3
Removing the Airway ShieldTM
Once the ETT is in place and the ventilator is connected, the Airway ShieldTM is peeled away from the midline and removed. The exposure to aerosols and droplets has been minimized.
The benefits
The Airway ShieldTM is a cost-effective, safe, and innovative solution for avoiding clinician exposure to aerosols and droplets during airway management.
Patient Safety
Facilitates intubation, making the procedure safer.
Operator Protection
Protects clinicians from the risk of infection.
Reduce Aerosols and Droplets
Reduces exposure for all involved in the procedure.
Easy to use
Minimal training required.
Portable
Available and ready to use in any circumstance.
Low-cost
Simple solution to a complex problem.
Disruptive technology
Revolutionary yet simple design.
Patented
Design and method protected by an international patent.
Testimonials
What the experts have to say about our device
Timeline
Our product roadmap with milestones from the conceptualization phase in April-May 2020 to our commercial launch in July-August 2021.
IDEA
First 3D Printing Prototypes
International Patent Filed (PCT)
Preclinical Studies Completed
Initial Contacts with Manufacturers
Design Optimization
Initial Distributors Selection
First Injection Molding Tool Contracted
First Clinical Study Design / Scientific Outreach Program Development
Preclinical Studies Under Review
Pre-Production Samples for Testing
Private Funding Round
Preclinical Studies Approved for Publication
Launch of Crowdfunding Campaign
COMMERCIAL LAUNCH
Partnerships
Awards
Get in touch
Spain
Calle Moctezuma 3, 1B Santander.
39003 Cantabria. Spain
+34 628 548 421
info@airwayshield.com